Laura Chiecchio

2.6k total citations
28 papers, 1.6k citations indexed

About

Laura Chiecchio is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Laura Chiecchio has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Laura Chiecchio's work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (8 papers). Laura Chiecchio is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (8 papers). Laura Chiecchio collaborates with scholars based in United Kingdom, Italy and United States. Laura Chiecchio's co-authors include Gareth J. Morgan, Gian Paolo Dagrada, Brian A. Walker, Faith E. Davies, Fiona M. Ross, Kevin Boyd, R.K.M. Protheroe, Christopher P. Wardell, Zoë J. Konn and Walter M. Gregory and has published in prestigious journals such as Blood, Clinical Cancer Research and Leukemia.

In The Last Decade

Laura Chiecchio

26 papers receiving 1.6k citations

Peers

Laura Chiecchio
Scott Van Wier United States
P. Leif Bergsagel United States
Victoria M. Garbitt United States
Letha A. Phillips United States
Zoë J. Konn United Kingdom
Phoenix A. Ho United States
Francesco Maura United States
Scott Van Wier United States
Laura Chiecchio
Citations per year, relative to Laura Chiecchio Laura Chiecchio (= 1×) peers Scott Van Wier

Countries citing papers authored by Laura Chiecchio

Since Specialization
Citations

This map shows the geographic impact of Laura Chiecchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Chiecchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Chiecchio more than expected).

Fields of papers citing papers by Laura Chiecchio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Chiecchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Chiecchio. The network helps show where Laura Chiecchio may publish in the future.

Co-authorship network of co-authors of Laura Chiecchio

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Chiecchio. A scholar is included among the top collaborators of Laura Chiecchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Chiecchio. Laura Chiecchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chiecchio, Laura. (2020). In situ hybridisation in tissue sections. Diagnostic histopathology. 26(11). 521–528. 2 indexed citations
3.
Boyd, Kevin, Fiona M. Ross, Laura Chiecchio, et al.. (2011). Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma. Cancer Epidemiology Biomarkers & Prevention. 20(8). 1703–1707. 33 indexed citations
4.
Boyd, Kevin, Fiona M. Ross, Brian A. Walker, et al.. (2011). Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival. Clinical Cancer Research. 17(24). 7776–7784. 131 indexed citations
5.
Boyd, Kevin, Fiona M. Ross, William Tapper, et al.. (2011). The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide‐based therapy. Genes Chromosomes and Cancer. 50(10). 765–774. 50 indexed citations
6.
Boyd, Kevin, F. M. Ross, Laura Chiecchio, et al.. (2011). A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia. 26(2). 349–355. 224 indexed citations
7.
Ross, F. M., Laura Chiecchio, Gian Paolo Dagrada, et al.. (2010). The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance. Haematologica. 95(7). 1221–1225. 69 indexed citations
8.
Walker, Brian A., Paola Leone, Laura Chiecchio, et al.. (2010). A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood. 116(15). e56–e65. 263 indexed citations
9.
Chiecchio, Laura, Gian Paolo Dagrada, Ashraf Ibrahim, et al.. (2009). Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica. 94(12). 1708–1713. 55 indexed citations
10.
Chiecchio, Laura, Gian Paolo Dagrada, R.K.M. Protheroe, et al.. (2009). Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case. Haematologica. 94(7). 1024–1028. 41 indexed citations
11.
Chiecchio, Laura, Gian Paolo Dagrada, Helen E. White, et al.. (2009). Frequent upregulation of MYC in plasma cell leukemia. Genes Chromosomes and Cancer. 48(7). 624–636. 45 indexed citations
12.
Leone, Paola, Brian A. Walker, Matthew Jenner, et al.. (2008). Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications. Clinical Cancer Research. 14(19). 6033–6041. 80 indexed citations
13.
Ross, Fiona, Andrew Fisher, P.W. Strike, et al.. (2007). Haemopoietic growth factors significantly improve the mitotic index and chromosome quality in cytogenetic cultures of myeloid neoplasia. Genes Chromosomes and Cancer. 46(7). 670–674. 3 indexed citations
14.
Włodarska, Iwona, Fiona M. Ross, Lisa J. Russell, et al.. (2007). Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.. Blood. 110(11). 991–991. 1 indexed citations
15.
Chiecchio, Laura, R.K.M. Protheroe, Ashraf Ibrahim, et al.. (2006). Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia. 20(9). 1610–1617. 104 indexed citations
16.
Ross, F. M., Ashraf Ibrahim, Laura Chiecchio, et al.. (2005). Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma. Leukemia. 19(9). 1634–1642. 54 indexed citations
17.
Risio, Mauro, Gaetano De Rosa, Ivana Sarotto, et al.. (2003). HER2 testing in gastric cancer: Molecular morphology and storage time-related changes in archival samples. International Journal of Oncology. 23(5). 1381–7. 24 indexed citations
18.
Porto, Beatriz, et al.. (2003). Role of haemoglobin in the protection of cultured lymphocytes against diepoxybutane (DEB), assessed by in vitro induced chromosome breakage. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 536(1-2). 61–67. 10 indexed citations
19.
Casorzo, Laura, Laura Chiecchio, Alberto Pisacane, et al.. (2003). Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genetics and Cytogenetics. 144(1). 61–64. 10 indexed citations
20.
Risio, Mauro, Laura Casorzo, Laura Chiecchio, Gaetano De Rosa, & Francesco Paolo Rossini. (2003). Deletions of 17p are associated with transition from early to advanced colorectal cancer. Cancer Genetics and Cytogenetics. 147(1). 44–49. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026